Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement

Imagem de Miniatura
Arquivos
art_ROSTA_Telemedicine_for_diabetes_management_during_COVID19_what_we_2023.PDF (648.96 KB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
ROSTA, Laszlo
MENYHART, Adrienn
MAHMEED, Wael Al
AL-RASADI, Khalid
AL-ALAWI, Kamila
BANACH, Maciej
BANERJEE, Yajnavalka
CERIELLO, Antonio
CESUR, Mustafa
COSENTINO, Francesco
Citação
FRONTIERS IN ENDOCRINOLOGY, v.14, article ID 1129793, 10p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The past two decades have witnessed telemedicine becoming a crucial part of health care as a method to facilitate doctor-patient interaction. Due to technological developments and the incremental acquisition of experience in its use, telemedicine's advantages and cost-effectiveness has led to it being recognised as specifically relevant to diabetology. However, the pandemic created new challenges for healthcare systems and the rate of development of digital services started to grow exponentially. It was soon discovered that COVID-19-infected patients with diabetes had an increased risk of both mortality and debilitating sequelae. In addition, it was observed that this higher risk could be attenuated primarily by maintaining optimal control of the patient's glucose metabolism. As opportunities for actual physical doctor-patient visits became restricted, telemedicine provided the most convenient opportunity to communicate with patients and maintain delivery of care. The wide range of experiences of health care provision during the pandemic has led to the development of several excellent strategies regarding the applicability of telemedicine across the whole spectrum of diabetes care. The continuation of these strategies is likely to benefit clinical practice even after the pandemic crisis is over.
Palavras-chave
telemedicine, type-2 diabetes (T2DM), COVID, 19, glucose monitoring, diabetes prevention and control, diabetes care
URI
https://observatorio.fm.usp.br/handle/OPI/54572
Referências
  1. Aiello M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030316
  2. Al Mahmeed W., 2021, MED, V8, DOI [10.3389/fcvm.2021.787761, DOI 10.3389/FCVM.2021.787761]
  3. Almathami HKY, 2020, J MED INTERNET RES, V22, DOI 10.2196/16407
  4. Almeida FA, 2020, CONTEMP CLIN TRIALS, V88, DOI 10.1016/j.cct.2019.105877
  5. Amer Diabet Assoc, 2022, DIABETES CARE, V45, pS1, DOI 10.2337/dc22-Sint
  6. Avdal EU, 2020, J INFECT PUBLIC HEAL, V13, P1892, DOI 10.1016/j.jiph.2020.03.008
  7. Ayar D, 2021, J PEDIATR RES, V8, P131, DOI 10.4274/jpr.galenos.2020.61214
  8. Aydogan BI., 2022, P ENDOKURS 6 ADANA
  9. Barany T., 2011, CARDIOL HUNG, V41, P231
  10. Benchoufi Mehdi, 2017, F1000Res, V6, P66, DOI 10.12688/f1000research.10531.5
  11. Bergenstal RM, 2021, DIABETES TECHNOL THE, V23, P128, DOI 10.1089/dia.2020.0396
  12. Bhaskar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.556789
  13. Bhaskar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.556720
  14. Bhaskar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00410
  15. Bian RR, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.4709
  16. Boddu SK, 2020, DIABETES METAB SYND, V14, P2211, DOI 10.1016/j.dsx.2020.11.012
  17. Bollyky JB, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3961730
  18. Borbas J, 2017, ORVOSI HETILAP, V158, P1741, DOI 10.1556/650.2017.30884
  19. Bray GA, 1999, DIABETES CARE, V22, P623
  20. Caffery LJ, 2016, J TELEMED TELECARE, V22, P504, DOI 10.1177/1357633X16670495
  21. Chen YC, 2020, DIABETES CARE, V43, P1399, DOI 10.2337/dc20-0660
  22. Chenthara S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243043
  23. Cichosz Simon Lebech, 2019, J Diabetes Sci Technol, V13, P248, DOI 10.1177/1932296818790281
  24. Davis J, 2022, SCI DIABETES SELF-MA, V48, DOI 10.1177/26350106211072203
  25. Davis RM, 2010, DIABETES CARE, V33, P1712, DOI 10.2337/dc09-1919
  26. Davis RM, 2009, CONTEMP CLIN TRIALS, V30, P63, DOI 10.1016/j.cct.2008.09.007
  27. De Groot J, 2021, WORLD J DIABETES, V12, P170, DOI 10.4239/wjd.v12.i2.170
  28. De Luca V, 2021, PROCEEDINGS OF THE 7TH INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGIES FOR AGEING WELL AND E-HEALTH (ICT4AWE), P130, DOI 10.5220/0010395901300136
  29. Dixon RF, 2020, J DIABETES SCI TECHN, V14, P908, DOI 10.1177/1932296819888662
  30. Fang HS, 2021, J MED INTERNET RES, V23, DOI 10.2196/25094
  31. Garg S, 2021, DIABETES TECHNOL THE, V23, pS15, DOI 10.1089/dia.2020.0656
  32. Garg SK, 2019, DIABETES TECHNOL THE, V21, pS1, DOI 10.1089/dia.2019.0090
  33. Glowczynska R, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-021-01292-9
  34. Grock S, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0948-2
  35. Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0
  36. Izquierdo RE, 2003, DIABETES CARE, V26, P1002, DOI 10.2337/diacare.26.4.1002
  37. Jain V, 2021, DIABETES CARE, V44, pE15, DOI 10.2337/dc20-2016
  38. Joiner KL, 2017, PREV MED, V100, P194, DOI 10.1016/j.ypmed.2017.04.033
  39. Kanat M, 2015, WORLD J DIABETES, V6, P1207, DOI 10.4239/wjd.v6.i12.1207
  40. Katula JA, 2022, AM J PREV MED, V62, P567, DOI 10.1016/j.amepre.2021.10.023
  41. Kempler P., 2021, METABOLIZMUS, V19, P60
  42. Kerr D, 2020, J DIABETES SCI TECHN, V14, P1107, DOI 10.1177/1932296820963630
  43. Khunti S, 2019, THER ADV ENDOCRINOL, V10, DOI 10.1177/2042018819844694
  44. Khuntia J, 2021, J MED INTERNET RES, V23, DOI 10.2196/30453
  45. Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
  46. Kuo TT, 2017, J AM MED INFORM ASSN, V24, P1211, DOI 10.1093/jamia/ocx068
  47. Lima-Martinez MM, 2021, CLIN INVEST ARTERIOS, V33, P151, DOI 10.1016/j.arteri.2020.10.001
  48. Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230
  49. Little P, 2016, LANCET DIABETES ENDO, V4, P821, DOI 10.1016/S2213-8587(16)30099-7
  50. Majithia AR, 2022, JMIR FORM RES, V6, DOI 10.2196/31629
  51. Mantovani A, 2020, NUTR METAB CARDIOVAS, V30, P1236, DOI 10.1016/j.numecd.2020.05.014
  52. memorial, US
  53. Nakamoto S., 2008, BITCOIN PEER TO PEER, P21260
  54. Ng WY, 2021, LANCET DIGIT HEALTH, V3, pE819, DOI 10.1016/S2589-7500(21)00210-7
  55. Ngiam KY, 2019, LANCET ONCOL, V20, pE262, DOI 10.1016/S1470-2045(19)30149-4
  56. Offringa Reid, 2018, J Diabetes Sci Technol, V12, P701, DOI 10.1177/1932296817747291
  57. Ozercan HI, 2018, GENOME RES, V28, P1255, DOI 10.1101/gr.207464.116
  58. Pantalone KM, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0699-7
  59. Patel SY, 2021, JAMA INTERN MED, V181, P1412, DOI 10.1001/jamainternmed.2021.3047
  60. Pereira K, 2015, DIABETES TECHNOL THE, V17, P55, DOI 10.1089/dia.2014.0155
  61. Petersen LS, 2017, STUD HEALTH TECHNOL, V245, P793, DOI 10.3233/978-1-61499-830-3-793
  62. Poduval S, 2022, JMIR HUM FACTORS, V9, DOI 10.2196/31567
  63. Polap D, 2021, J INF SECUR APPL, V58, DOI 10.1016/j.jisa.2021.102748
  64. Polonsky William H, 2020, Clin Diabetes, V38, P357, DOI 10.2337/cd19-0105
  65. Rahman MA, 2020, IEEE ACCESS, V8, P205071, DOI 10.1109/ACCESS.2020.3037474
  66. Ramadas A, 2011, INT J MED INFORM, V80, P389, DOI 10.1016/j.ijmedinf.2011.02.002
  67. resmigazete, US
  68. Rosta L., 2022, DIABETOLOGIA HUNGARI, V30, P11
  69. Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157
  70. Steenblock C, 2022, HORM METAB RES, V54, P503, DOI 10.1055/a-1878-9566
  71. The Government of Hungary, 2020, MAGYAR KOZLONY, V91, P2284
  72. Tian HB, 2019, J MED SYST, V43, DOI 10.1007/s10916-018-1144-x
  73. Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
  74. Vimalananda VG, 2015, J TELEMED TELECARE, V21, P323, DOI 10.1177/1357633X15582108
  75. Wade VA, 2014, QUAL HEALTH RES, V24, P682, DOI 10.1177/1049732314528809
  76. WHO, 1998, HLTH TEL POL SUPP WH, P11
  77. Wosik J, 2020, J AM MED INFORM ASSN, V27, P957, DOI 10.1093/jamia/ocaa067
  78. Yildirim P., 2017, BILI IM TEKNOLOJILER, V10, P153, DOI [10.17671/gazibtd.309295, DOI 10.17671/GAZIBTD.309295]
  79. Zhang AQ, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19074173
  80. Zhang B, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/6643491
  81. Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
  82. Zhu LH, 2020, CELL METAB, V31, P1068, DOI 10.1016/j.cmet.2020.04.021

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03